WASHINGTON, March 16 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated March 5, 2025, from the National Organization for Rare Disorders: * * * To: Jacqueline Corrigan-Curay, J.D., M.D. Acting Director, Center for Drug Evaluation and Research U.S. Food and Drug Administration 10001 New Hampshire Ave Silver Spring, MD 20903 * Peter Marks, M.D. Director, Center for Biologics Evaluation and Research U.S. F more ST